160毫米快速切换双能CT(rsDECT)生成的肝脏虚拟平扫图像:与原生平扫图像在衰减值准确性及实性肝脏病灶显著性上的比较
回顾性纳入73例确诊原发性或转移性肝肿瘤患者,行多期增强快速切换双能CT,比较动脉期虚拟平扫(VUEart)和门静脉期虚拟平扫(VUEport)与原生平扫(NU)的肝脏及病灶衰减值、病灶-肝对比噪声比(LL-CNR)及病灶显著性差异。VUEport与NU在肝实质和病灶衰减值上可比,VUEart肝实质衰减值低于NU,VUEart和VUEport的LL-CNR均高于NU且VUEport病灶显著性优于NU,作者认为VUEport可自信替代NU。
要点
- VUEport图像肝实质和病灶衰减值与NU可比,LL-CNR高于NU(1.6±1.1 vs 0.9±0.6,p<0.001),病灶显著性也优于NU(p<0.001)。
- VUEart肝实质平均衰减值低于NU(56.7±6.7 HU vs 59.6±7.5 HU,p=0.008),VUEart与VUEport间及VUEport与NU间无显著差异。
- VUEart和VUEport与NU在肝病灶及无瘤肝实质衰减值上均呈强相关(r=0.82-0.91,p<0.01)。
诊断标准与关键数值
- 肝实质平均衰减值:VUEart 56.7±6.7 HU显著低于NU 59.6±7.5 HU(p=0.008);VUEart与VUEport 57.9±6 UH无显著差异(p=0.38);VUEport与NU无显著差异(p=0.051)。
- 肝病灶平均衰减值在NU、VUEart和VUEport间可比(p=0.60)。
- 肝病灶和无瘤肝实质中VUE与NU衰减值均呈强且显著相关(r=0.82-0.91,p<0.01)。
- LL-CNR:VUEart 1.7±1和VUEport 1.6±1.1均显著高于NU 0.9±0.6(p<0.001);VUEart与VUEport间无显著差异(p>0.9)。
- 病灶显著性:VUEport显著高于NU(p<0.001)。
临床应用与阅片要点
- 作者认为VUEport图像在恶性肝病灶评估患者中可自信替代NU图像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the reliability of attenuation values of the liver parenchyma and focal liver lesions on virtual unenhanced images from arterial (VUEart) and portal venous phases (VUEport) compared to native unenhanced (NU) attenuation values in patients referred for assessment of malignant liver lesions.
METHODS: Seventy-three patients with confirmed primary or metastatic liver tumors who underwent a multiphase contrast-enhanced rapid-switching kVp dual-energy CT (rsDECT) were included in this IRB-approved retrospective study. Both qualitative and quantitative analyses - including the lesion-to-liver contrast-to-noise ratio (LL-CNR) - were performed and compared between NU and both VUEart and VUEport images.
RESULTS: The mean liver attenuation values were significantly lower in VUEart images (56.7 ± 6.7 HU) than in NU images (59.6 ± 7.5 HU, p = 0.008), and were comparable between VUEart and VUEport images (57.9 ± 6 UH, p = 0.38) and between VUEport and NU images (p = 0.051). The mean liver lesions attenuation values were comparable between NU, VUEart and VUEport images (p = 0.60). Strong and significant correlations values were found both in liver lesions and tumor-free parenchyma (r = 0.82-0.91, p < 0.01). The mean LL-CNR was significantly higher in VUEart and VUEport images than in NU images (1.7 ± 1 and 1.6 ± 1.1 vs 0.9 ± 0.6; p < 0.001), but was comparable between VUEart and VUEport images (p > 0.9). Lesion conspicuity was significantly higher in VUEport images than in NU images (p < 0.001).
CONCLUSION: VUEport images derived from 3rd generation rsDECT could confidently replace NU images in patients undergoing assessment for malignant liver lesions. These images provide comparable attenuation values in both liver lesions and liver parenchyma while reducing the radiation dose and scanning time.
引用
- Lacroix M, Mulé S, Herin E, et al. Virtual unenhanced imaging of the liver derived from 160-mm rapid-switching dual-energy CT (rsDECT): Comparison of the accuracy of attenuation values and solid liver lesion conspicuity with native unenhanced images. Eur J Radiol. 2020. PMID: 33166833. doi:10.1016/j.ejrad.2020.109387
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。